.RESEARCH HIGHLIGHT.06 August 2024.
A huge randomized regulated test with cisgender ladies highlights the obstacles of obedience to a regular oral preexposure treatment program as well as demonstrates that twice-yearly treatment of lenacapavir can sustain successful HIV avoidance degrees over 6 months.